Faculty who have authored publication Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial.
| Name | Title | Department | Institution |
|---|---|---|---|
| Kenneth Brian Gordon MD | Chair, Professor | Dermatology | Medical College of Wisconsin |
